This focused edition on “Upper-Tract Urothelial Carcinoma: Current State and Future Directions” will explore a breadth of topics surround UTUC, to bring into focus up-to-date discussions. Highlighted topics include epidemiology, risk stratification and the challenges of diagnosis; outcomes of organ-sparing surgery, tips and tricks, and future directions; outcomes of radical surgery including complications, the role of lymph node dissection, the role of perioperative chemotherapy, management of the bladder cuff, and bladder recurrence following UTUC.
We thank the authors for the remarkable time and effort put forth, which made this special series possible. We are privileged for their contribution, and hope that the totality of their work will make a meaningful contribution to your practice.
An editorial comment for the special series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions”
Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy
Incidence and preoperative predictors for major complications following radical nephroureterectomy
Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
Risk stratification for upper tract urinary carcinoma
Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
Endoscopic management of upper tract urothelial carcinoma—tips and tricks
Outcomes of endoscopic management of upper tract urothelial carcinoma
Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma
Oncologic outcomes of radical nephroureterectomy (RNU)
Perioperative complications and adverse sequelae of radical nephroureterectomy
The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
Controversies in management of the bladder cuff at nephroureterectomy
Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
Disclosure:
The series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. John J. Knoedler and Jay D. Raman served as the unpaid Guest Editors for the series.